4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001193125-26-291163
Director sold 1,438,163 shares at an average $34.32 ($49,354,076)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gold Daniel Allen Director | 2026-06-26 | Sale | −300,783 | $33.92 | $10,202,559 | 14,826,546 | I: show line 1 in the form |
| Gold Daniel Allen Director | 2026-06-26 | Sale | −325,000 | $34.07 | $11,072,750 | 14,501,546 | I: show line 2 in the form |
| Gold Daniel Allen Director | 2026-06-29 | Sale | −200,000 | $34.44 | $6,888,000 | 14,301,546 | I: show line 3 in the form |
| Gold Daniel Allen Director | 2026-06-29 | Sale | −600,000 | $34.59 | $20,754,000 | 13,701,546 | I: show line 4 in the form |
| Gold Daniel Allen Director | 2026-06-30 | Sale | −12,380 | $35.28 | $436,766 | 13,689,166 | I: show line 5 in the form |
| Open-market sales · 1,438,163 sh · avg $34.32 · $49,354,076 | |||||||
Loading xslF345X06/ownership.xml…